Oculis Holding AG (OCS) Non Operating Income (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Non Operating Income came in at -$9.2 million in Q1 2026, up 37.34% year-on-year from -$6.7 million in Q1 2025, and down 140.65% quarter-over-quarter from -$3.8 million in Q4 2025.

Oculis Holding AG (OCS) Non Operating Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Non Operating Income history runs 5 years deep, the most recent figure standing at -$9.2 million for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 37.34% year-over-year to -$9.2 million in Q1 2026; TTM through Mar 2026 was $6.9 billion, a 387.62% increase from a year earlier, with the FY2025 full-year figure at -$21.1 million, down 45.59% from the prior year.
  • Non Operating Income eased to -$9.2 million in Q1 2026 per OCS's latest filing, from -$3.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.9 billion in Q3 2025 and bottomed at -$2.4 billion in Q3 2024.
  • The 5-year median for Non Operating Income is -$3.5 million (2022), against an average of $278.1 million.
  • Across the five-year window, Non Operating Income tumbled 45430.84% in 2024 and soared 391.6% in 2025, its largest moves.
  • Year by year, Non Operating Income stood at -$5.6 million in 2022, then surged by 93.45% to -$369772.3 in 2023, then slumped by 3491.22% to -$13.3 million in 2024, then jumped by 71.14% to -$3.8 million in 2025, then slumped by 140.65% to -$9.2 million in 2026.
  • Per Business Quant, the three latest OCS Non Operating Income figures stand at -$9.2 million (Q1 2026), -$3.8 million (Q4 2025), and $6.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -46.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.22 Mn
Dec 31, 2025 -3.83 Mn
Sep 30, 2025 6.87 Bn
Jun 30, 2025 -5.59 Mn
Mar 31, 2025 -14.72 Mn
Dec 31, 2024 -13.28 Mn
Sep 30, 2024 -2.36 Bn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -1.90 Mn
Dec 31, 2023 -369,772.27
Sep 30, 2023 -5.17 Mn
Jun 30, 2023 -2.24 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 -5.65 Mn
Sep 30, 2022 -3.18 Mn
Jun 30, 2022 -3.18 Mn